BioCentury
ARTICLE | Clinical News

Genervon preclinical data

January 14, 2013 8:00 AM UTC

In a mouse model of ALS with mutant superoxide dismutase 1 (SOD1), GM604 significantly improved clinical scores vs. vehicle-treated controls (p<0.001). GM604 also delayed time to onset of ALS symptom...